Orchestra BioMed Holdings(OBIO)
$6.01+0.28 (+4.89%)
OBIO
Orchestra BioMed Holdings Revenue
$6.01
At close:+0.28 (+4.89%)
Want to see OBIO full AI Analyst Report?
Orchestra BioMed Holdings (OBIO) Revenue
120 Followers
Orchestra BioMed Holdings Revenue
Orchestra BioMed Holdings had a revenue of 88.00K in the quarter ending Jun 30, 2026, with -20.00%. This bring the company's revenue in the last twelve months to 31.98M, Decreased 2.29%. In the fiscal year ending Dec 31, 2025, Orchestra BioMed Holdings had annual revenue of 33.48M with 1169.22% growth.
- Revenue (ttm)
- 31.98M
- Revenue Growth
- 1007.38%
- P/S Ratio
- 10.29
- Revenue/Employee
- $389,326
- Employees
- 86
- Market Cap
- $344.40M
Revenue Chart
Orchestra BioMed Holdings Revenue - Annual
Revenue History
| Fiscal End Date | Revenue | Change | Growth |
|---|---|---|---|
| Dec 31, 2025 | 33.48M | 30.84M | 1169.22% |
| Mar 31, 2025 | 2.64M | -122.00K | -4.42% |
| Dec 31, 2023 | 2.76M | -773.00K | -21.88% |
| Dec 31, 2022 | 3.53M | 4.32M | -551.79% |
| Dec 31, 2021 | -782.00K | -6.49M | -113.71% |
| Dec 31, 2020 | 5.70M | ― | ― |
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.